Literature DB >> 7398137

Tissue distribution of orally administered bismuth in the rat.

S P Lee, T H Lim, J Pybus, A C Clarke.   

Abstract

1. A colloidal bismuth preparation, tripotassium dicitrato-bismuthate, was given (172 mg/kg body weight, 6/7 days) to 10 laboratory rats for 14 months. Bismuth was measured by atomic absorption spectrometry in various tissues and the pattern of distribution studied. 2. Bismuth was present in kidney lung, spleen, liver, brain, heart and skeletal muscles, in descending order of abundance. Haematological data, renal and liver function tests were normal in the bismuth-treated group. 3. The data suggested that chronic ingestion of bismuth in large doses in rats results in absorption and binding to tissues. Absorbed bismuth probably crosses the blood-brain barrier.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7398137     DOI: 10.1111/j.1440-1681.1980.tb00076.x

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  10 in total

Review 1.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

2.  Reversible toxicity in poisoning with colloidal bismuth subcitrate.

Authors:  M Hudson; N A Mowat
Journal:  BMJ       Date:  1989-07-15

3.  Location of bacteria in the mid-colon of the rat.

Authors:  J E Bollard; M A Vanderwee; G W Smith; C Tasman-Jones; J B Gavin; S P Lee
Journal:  Appl Environ Microbiol       Date:  1986-03       Impact factor: 4.792

4.  Preservation of mucus in situ in rat colon.

Authors:  J E Bollard; M A Vanderwee; G W Smith; C Tasman-Jones; J B Gavin; S P Lee
Journal:  Dig Dis Sci       Date:  1986-12       Impact factor: 3.199

Review 5.  Colloidal bismuth subcitrate. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in peptic ulcer disease.

Authors:  A J Wagstaff; P Benfield; J P Monk
Journal:  Drugs       Date:  1988-08       Impact factor: 9.546

6.  Bismuth ions inhibit the biological activity of non-amidated gastrins in vivo.

Authors:  Suzana Kovac; Su-Wen Loh; Shamilah Lachal; Arthur Shulkes; Graham S Baldwin
Journal:  Biochem Pharmacol       Date:  2011-12-08       Impact factor: 5.858

7.  Uptake and subcellular localisation of bismuth in the gastrointestinal mucosa of rats after short term administration of colloidal bismuth subcitrate.

Authors:  D Stiel; D J Murray; T J Peters
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

Review 8.  Pharmacokinetics and toxicity of bismuth compounds.

Authors:  A Slikkerveer; F A de Wolff
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct

9.  Bioavailability of bismuth from 205Bi-labelled pharmaceutical oral Bi-preparations in rats.

Authors:  B Dresow; P Nielsen; R Fischer; J Wendel; E E Gabbe; H C Heinrich
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

10.  Labeling Stem Cells with a New Hybrid Bismuth/Carbon Nanotube Contrast Agent for X-Ray Imaging.

Authors:  Mayra Hernández-Rivera; Stephen Y Cho; Sakineh E Moghaddam; Benjamin Y Cheong; Maria da Graça Cabreira-Hansen; James T Willerson; Emerson C Perin; Lon J Wilson
Journal:  Contrast Media Mol Imaging       Date:  2019-06-11       Impact factor: 3.161

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.